• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表达毒素共调节菌毛的假定增强型口服霍乱疫苗菌株的生产。

Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.

作者信息

Hauke Caitlyn A, Taylor Ronald K

机构信息

Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America.

出版信息

PLoS One. 2017 Apr 6;12(4):e0175170. doi: 10.1371/journal.pone.0175170. eCollection 2017.

DOI:10.1371/journal.pone.0175170
PMID:28384206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5383245/
Abstract

The use of whole cell killed (WCK) oral cholera vaccines is an important strategy for cholera prevention in endemic areas. To overcome current vaccine limitations, we engineered strains of V. cholerae to be non-toxigenic and to express the protective protein colonization factor, toxin-coregulated pilus (TCP), under scale-up conditions potentially amenable to vaccine production. Two V. cholerae clinical strains were selected and their cholera toxin genes deleted. The tcp operon was placed under control of a rhamnose-inducible promoter. Production and stability of TCP were assessed under various conditions. The strains lack detectable cholera toxin production. The addition of 0.1% rhamnose to the growth medium induced robust production of TCP and TcpA antigen. The strains produced intact TCP in larger growth volumes (1 L), and pili appeared stable during heat-killing or acid treatment of the bacterial cultures. To date, no WCK cholera vaccines have included TCP. We have constructed putative strains of V. cholerae for use in a vaccine that produce high levels of stable TCP antigen, which has not previously been achieved.

摘要

使用全细胞灭活(WCK)口服霍乱疫苗是流行地区预防霍乱的一项重要策略。为克服当前疫苗的局限性,我们对霍乱弧菌菌株进行改造,使其不产毒素,并在可能适合疫苗生产的放大培养条件下表达保护性蛋白定居因子——毒素协同菌毛(TCP)。选择了两株霍乱弧菌临床菌株,并删除了它们的霍乱毒素基因。将tcp操纵子置于鼠李糖诱导型启动子的控制之下。在各种条件下评估TCP的产生和稳定性。这些菌株检测不到霍乱毒素的产生。向生长培养基中添加0.1%的鼠李糖可诱导TCP和TcpA抗原的大量产生。这些菌株在更大的培养体积(1升)中产生完整的TCP,并且在对细菌培养物进行热灭活或酸处理期间菌毛似乎是稳定的。迄今为止,尚无WCK霍乱疫苗包含TCP。我们构建了用于疫苗的假定霍乱弧菌菌株,这些菌株可产生高水平的稳定TCP抗原,而这是以前未曾实现的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/ada03a594efa/pone.0175170.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/3c5330fa828a/pone.0175170.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/d6a6198240e7/pone.0175170.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/6568c52e6f6d/pone.0175170.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/a29fd1d16c8f/pone.0175170.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/ada03a594efa/pone.0175170.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/3c5330fa828a/pone.0175170.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/d6a6198240e7/pone.0175170.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/6568c52e6f6d/pone.0175170.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/a29fd1d16c8f/pone.0175170.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c234/5383245/ada03a594efa/pone.0175170.g005.jpg

相似文献

1
Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.表达毒素共调节菌毛的假定增强型口服霍乱疫苗菌株的生产。
PLoS One. 2017 Apr 6;12(4):e0175170. doi: 10.1371/journal.pone.0175170. eCollection 2017.
2
Inactivated Strains That Express TcpA via the -139F Allele Induce Antibody Responses against TcpA.通过 -139F 等位基因表达 TcpA 的失活菌株诱导针对 TcpA 的抗体应答。
J Microbiol Biotechnol. 2022 Nov 28;32(11):1396-1405. doi: 10.4014/jmb.2209.09001. Epub 2022 Oct 12.
3
A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.霍乱弧菌经典型毒素共调节菌毛蛋白A(TcpA)氨基酸序列可诱导产生保护性抗体,该抗体可结合一个被推测对毒素共调节菌毛结构很重要的区域。
Infect Immun. 2004 Oct;72(10):6050-60. doi: 10.1128/IAI.72.10.6050-6060.2004.
4
Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.霍乱弧菌E1 Tor型毒素共调节菌毛的致病及疫苗意义
J Biotechnol. 1999 Aug 20;73(2-3):109-17. doi: 10.1016/s0168-1656(99)00114-5.
5
Clinical and environmental isolates of Vibrio cholerae serogroup O141 carry the CTX phage and the genes encoding the toxin-coregulated pili.霍乱弧菌O141血清群的临床分离株和环境分离株携带CTX噬菌体以及编码毒素调节菌毛的基因。
J Clin Microbiol. 2001 Nov;39(11):4086-92. doi: 10.1128/JCM.39.11.4086-4092.2001.
6
Immunizing adult female mice with a TcpA-A2-CTB chimera provides a high level of protection for their pups in the infant mouse model of cholera.用TcpA-A2-CTB嵌合体免疫成年雌性小鼠,在霍乱幼鼠模型中能为其幼崽提供高水平的保护。
PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3356. doi: 10.1371/journal.pntd.0003356. eCollection 2014 Dec.
7
Anti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotype.抗II类单克隆抗体靶向的霍乱弧菌TcpA菌毛蛋白:血清学反应、表位特异性和同种型的调节
Infect Immun. 2001 Dec;69(12):7679-86. doi: 10.1128/IAI.69.12.7679-7686.2001.
8
Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.针对从霍乱弧菌分离出的毒素共调节菌毛的抗体,在幼鼠实验性霍乱模型中提供保护作用。
J Infect Dis. 1990 Jun;161(6):1231-6. doi: 10.1093/infdis/161.6.1231.
9
Safe, live Vibrio cholerae vaccines?
Vaccine. 1988 Apr;6(2):151-4. doi: 10.1016/s0264-410x(88)80019-7.
10
The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model.
Microb Pathog. 1989 Dec;7(6):437-48. doi: 10.1016/0882-4010(89)90024-7.

引用本文的文献

1
, classification, pathogenesis, immune response, and trends in vaccine development.分类、发病机制、免疫反应及疫苗研发趋势。
Front Med (Lausanne). 2023 May 5;10:1155751. doi: 10.3389/fmed.2023.1155751. eCollection 2023.
2
Recombinant Globular Domain of TcpA Pilin from El Tor: Recovery from Inclusion Bodies and Structural Characterization.来自埃尔托生物型霍乱弧菌的TcpA菌毛蛋白的重组球状结构域:从包涵体中回收及结构表征
Life (Basel). 2022 Nov 7;12(11):1802. doi: 10.3390/life12111802.
3
Inactivated Strains That Express TcpA via the -139F Allele Induce Antibody Responses against TcpA.

本文引用的文献

1
A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines.在菲律宾进行的一项随机、非劣效性试验,比较两种二价灭活全细胞口服霍乱疫苗(Euvichol与Shanchol)。
Vaccine. 2015 Nov 17;33(46):6360-5. doi: 10.1016/j.vaccine.2015.08.075. Epub 2015 Sep 5.
2
Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial.孟加拉国城市流行地区口服霍乱疫苗的可行性和有效性:一项整群随机开放标签试验。
Lancet. 2015 Oct 3;386(10001):1362-1371. doi: 10.1016/S0140-6736(15)61140-0. Epub 2015 Jul 9.
3
通过 -139F 等位基因表达 TcpA 的失活菌株诱导针对 TcpA 的抗体应答。
J Microbiol Biotechnol. 2022 Nov 28;32(11):1396-1405. doi: 10.4014/jmb.2209.09001. Epub 2022 Oct 12.
4
Immunomodulatory effects of mesenchymal stem cell-conditioned media on lipopolysaccharide of Vibrio cholerae as a vaccine candidate.间充质干细胞条件培养基对霍乱弧菌脂多糖作为疫苗候选物的免疫调节作用。
Stem Cell Res Ther. 2021 Nov 3;12(1):564. doi: 10.1186/s13287-021-02622-0.
Cholera outbreaks in the El Tor biotype era and the impact of the new El Tor variants.
埃尔托生物型时代的霍乱暴发及新埃尔托变异株的影响。
Curr Top Microbiol Immunol. 2014;379:17-47. doi: 10.1007/82_2014_363.
4
5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.印度加尔各答两价口服霍乱全细胞疫苗 5 年有效性:一项集群随机、双盲、安慰剂对照试验。
Lancet Infect Dis. 2013 Dec;13(12):1050-6. doi: 10.1016/S1473-3099(13)70273-1. Epub 2013 Oct 18.
5
The global burden of cholera.霍乱的全球负担。
Bull World Health Organ. 2012 Mar 1;90(3):209-218A. doi: 10.2471/BLT.11.093427. Epub 2012 Jan 24.
6
Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes.从孟加拉国和海地分离的霍乱弧菌 O1 型 El Tor 生物型变异株的特性分析,包括毒力基因的分子遗传学分析。
J Clin Microbiol. 2011 Nov;49(11):3739-49. doi: 10.1128/JCM.01286-11. Epub 2011 Aug 31.
7
Vibrio cholerae: lessons for mucosal vaccine design.霍乱弧菌:黏膜疫苗设计的启示。
Expert Rev Vaccines. 2011 Jan;10(1):79-94. doi: 10.1586/erv.10.150.
8
Growth and laboratory maintenance of Vibrio cholerae.霍乱弧菌的生长及实验室培养
Curr Protoc Microbiol. 2010 May;Chapter 6:Unit 6A.1. doi: 10.1002/9780471729259.mc06a01s17.
9
Cholera vaccines: WHO position paper.霍乱疫苗:世界卫生组织立场文件。
Wkly Epidemiol Rec. 2010 Mar 26;85(13):117-28.
10
Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.一种新型保护性单克隆抗体的特性鉴定,该抗体识别霍乱弧菌小川型和稻叶型血清型共有的一个表位。
Microbiology (Reading). 2009 Jul;155(Pt 7):2353-2364. doi: 10.1099/mic.0.025726-0. Epub 2009 Apr 23.